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ABSTRACT
Bronchiectasis is a common disease caused by chronic infection in the small airways of the 
lungs. Patients often carry a heavy burden of symptoms.  Unfortunately, little is known about 
the impact of bronchiectasis on Australians or on our healthcare system. For many years, 
bronchiectasis was considered as another Chronic Obstructive Pulmonary Disease and was 
bundled (for costing purposes) with COPD or other pulmonary infections, without 
recognition that the condition was associated with significant, particular clinical features that 
required longer and more complex admissions to hospital than COPD.  Prior to July 2018, 
there was no disease specific code within the system that allocates hospital funding and 
consequently, episodes of care for patients with bronchiectasis were assigned into other 
respiratory illness in the AR-DRG system. This misallocation is likely to have affected 
hospital funding which is calculated based on ALOS associated with the AR-DRG group of 
diseases. The main purpose of this thesis was to explore the factors contributing to the length 
of stay and hospital readmission for patients with bronchiectasis in Australia in three parts; 
i) An evaluation of the effect of a specific AR-DRG on funding of length of hospital stay for
bronchiectasis patients and a comparison of the actual length of stay in hospital (LOS) with
the average length of stay (ALOS) based on the assigned AR-DRG. We found that the AR-
DRG system consistently underestimated the LOS and costs for acute hospital admissions
due to bronchiectasis.
ii) An investigation of the effect of seasonality of presentation and patient characteristics
(sex, age, smoking status, ABR registry status) on hospital LOS and ALOS. The cohort in
this study included 299 patients who were diagnosed as bronchiectasis with 505 admissions
of >24 hours to Concord Hospital, NSW between July 2011-June 2018. The results were
showing significance ( 0.05) between the non ABR-registry and the response .
This implied that bronchiectasis patients who participated with ABR- registry tend to have
length of stay in hospital shorter than patients who did not register in the ABR.
iii) An analysis of the time between episodes of care of bronchiectasis patients using
longitudinal data analysis and multilevel models. Bronchiectasis patients who were smokers
and hospital LOS, were statistically significant risk factors for readmission. Hospital LOS
was negatively correlated with time to readmission suggesting that longer stays in hospital
can reduce readmission risk. In addition, patients who were smokers had a significantly
higher readmission rate than patients who were not smokers.
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